Jose O. Solbiati, Ph.D.

Dr. Solbiati is currently conducting research at the University of Florida. He also served at the University of Illinois for over 10 years after being employed both in Argentina and Spain upon completion of his PhD in Argentina. Dr. Solbiati has been collaborating with Dr. Dennis Buetow and Dr. Indu Rupassara on the research related to genetic engineering to stabilize the RSV gene.
More Details

Jagdeep S. Sandhu, Ph.D.

Dr. Sandhu obtained his PhD from the University of Cambridge, UK, in 1996. He conducted postgraduate research on transfer of the RSV fusion-protein into plants, at the University of Illinois at Urbana-Champaign (1996-2000, in Buetow-lab), and then as a biotechnologist at the Punjab Agricultural University, India, where he is employed at present.
More Details

Erik Nelson, Ph.D.

Erik Nelson received his Bachelors of Science from the University of Calgary, majoring in zoology and minoring in chemistry. He continued at the University of Calgary, receiving a PhD in comparative endocrinology. He then moved to Duke University School of Medicine to pursue postdoctoral studies specializing in pharmacology and cancer biology. In 2014, he was recruited to the University of Illinois at Urbana-Champaign, where he is an Assistant Professor of Molecular and Integrative Physiology. His research program is focused on how hormones and cholesterol metabolism impact breast and ovarian cancer progression. In recognition of his research, Dr. Nelson has been awarded the Government of Alberta Queen Elizabeth II Graduate Scholarship, a Department of Defense Breast Cancer Research Program Postdoctoral Fellowship Award, and a National Cancer Institute Pathway to Independence Award.

Brenda Anne Wilson, Ph.D.

Dr. Wilson is a Professor of Microbiology and Associate Director of Undergraduate Education in the School of Molecular & Cellular Biology, College of Liberal Arts and Sciences, with a joint appointment in Pathobiology, College of Veterinary Medicine, at the University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. She is also an Inaugural Professor in the Carle Illinois College of Medicine. Dr. Wilson earned her B.A. degree in Biochemistry and German from Barnard College, Columbia University, in New York, and her M.S.-Ph.D. degrees in Chemistry from the Johns Hopkins University in Baltimore, Maryland, where she studied β-lactam antibiotics. Dr. Wilson began her studies on bacterial protein toxins as a microbiology postdoctoral fellow at Harvard Medical School. Her first tenured faculty appointment was in Biochemistry at Wright State University School of Medicine in Dayton, Ohio. In 1999, she joined the Department of Microbiology at the University of Illinois at Urbana-Champaign. Her research focuses on host-microbe interactions: studying the structure and function and molecular evolution of bacterial protein toxins, their molecular interactions with and biochemical effects on eukaryotic host target cells; developing novel post-exposure antitoxin therapeutics and toxin-based therapeutic delivery platforms; and exploiting comparative and functional genomic technologies to study extensively drug resistant bacteria and microbiomes in health and disease.

Hugh S. Mason, Ph.D.

Dr. Mason was the first to publish peer-reviewed work on the use of plants for production of vaccine antigens, showing expression of authentic hepatitis B surface antigen in tobacco (Mason et al., 1992). He was a leader in this field for many years and continue to publish work in plant-based vaccines (Kim et al., 2015). With funding from NIH-NIAID, Dr. Mason focused on oral delivery of vaccines for enteric diseases including Norwalk virus (Mason et al., 1996) and enterotoxic E. coli (Haq et al., 1995), and demonstrated oral immunogenicity in mice after ingestion of transgenic potato tuber.

More Details